The GLP-1 Conversation We Need to Have

Over the last 15 years in practice, I’ve watched trends cycle through. 

A few years ago: “Should I go keto?”
Before that: “Should I go vegan?”
Before that: “Should I cut out gluten?”

Right now, the conversation is: “What’s your take on GLP-1 meds?”

Quick context: GLP-1 is a hormone your body makes naturally after eating. It regulates blood sugar, slows digestion, and signals satiety to your brain. The medications everyone’s talking about—Ozempic, Wegovy, Mounjaro—are GLP-1 receptor agonists. They mimic this hormone but at much higher levels and for much longer than what your body produces on its own. The result is powerful appetite suppression and metabolic shifts. For ease, I’ll refer to them as GLP-1s.

For some, these medications are genuinely helpful. But here’s what keeps coming up in my practice: What happens when you stop? Recent data shows most people regain two-thirds of their weight within a year of stopping GLP-1s. 

The medication creates space—but without the right infrastructure to sustain that space, you end up right back where you started. So the real conversation isn’t whether to take one. It’s what needs to come with it.

What’s Actually True

GLP-1s are powerful. Legitimately powerful.

They reduce appetite, improve blood sugar control, lower cardiovascular risk, and reduce inflammation. We’re seeing benefits in heart disease, kidney disease, fatty liver, even autoimmune conditions. That’s not marketing—that’s real data.

And there’s emerging research on GLP-1s for Alzheimer’s prevention that’s genuinely intriguing. These aren’t just weight loss drugs—they’re metabolic regulators with far-reaching anti-inflammatory effects throughout the body.

I’m personally interested in very low-dose use—not for dramatic weight loss, but for metabolic regulation and inflammation control as part of a longevity medicine approach. That’s a quieter, more nuanced conversation. And one I think we’ll hear a lot more about in the coming years.

What I’m cautious about is the way they’re being used—quickly, casually, without enough conversation about what needs to come with them. Because a drug this powerful deserves a system around it.

And most people aren’t getting that system.

The Three Things Nobody’s Talking About

Muscle Loss (and “Ozempic Face”)

When appetite drops, people don’t automatically eat better. They just eat less. Of everything.

Less protein. Less fiber. Fewer micronutrients. Less variety.

If you’re on a GLP-1 and not paying attention to what you’re eating, you’re not just losing fat. You’re losing muscle. And the visible sign? Facial volume loss—what people call “Ozempic face.” But that’s just the part you can see. The real problem is muscle loss everywhere.

Muscle isn’t vanity—it’s your insurance policy. It’s what keeps your blood sugar stable, protects your bones, and keeps you capable in your body as you age.

Gut Disruption

GLP-1 therapies alter how food moves through your gut and change your microbiome composition. Some changes are beneficial, but appetite suppression and reduced nutrient intake can decrease microbiome diversity and increase inflammation.

I’ve seen people feel great initially, then months later develop bloating, constipation, food sensitivities, or inflammatory flares they didn’t have before.

At TNC, we test gut microbiomes for clients on GLP-1s—especially those with a history of digestive issues, autoimmunity, or chronic inflammation. Because guessing isn’t enough here.

Bone Density

Here’s what the research shows: GLP-1s combined with exercise preserve bone density. But GLP-1 therapy alone—without exercise—is associated with reduced bone mineral density.

If you’re on a GLP-1 and not strength training, you’re at risk of losing bone along with weight. And bone matters for your mobility, independence, and quality of life 10, 20, 30 years from now.

The Part That Actually Worries Me

We live in a society that celebrates weight loss like it’s a moral achievement.

Smaller is treated as better—even when the cost is strength, resilience, and healthspan. GLP-1s are being handed out like candy. Often with little conversation about nutrition support, muscle protection, or psychological readiness.

This feeds into one of the most disturbing narratives in our culture:

Small is better.

Small at any cost.

Not small and strong. Not small and healthy. Just… small.

The Psychology Behind the Why
(and What’s Really Driving Cravings)

Here’s what’s fascinating: GLP-1s work directly on your brain’s reward pathways. They modulate dopamine in areas like the nucleus accumbens—the same circuits involved in addiction. They literally turn down the “reward salience” of food, alcohol, even drugs. That’s why people talk about “food noise” stopping.

And some people genuinely need that space. When food noise is overwhelming and constant, it gets in the way of everything. GLP-1 can quiet that craving noise long enough for someone to catch their breath and start building new patterns.

But here’s what I believe: Cravings are telling us something.

Cravings don’t just come from lack of willpower—they come from physiology. Dopamine dysregulation. Blood sugar instability. Nutrient deficiencies. Gut microbiome imbalances. And yes, psychological patterns where food is being used as a soother for something deeper.

For years, we’ve told people with cravings that they lack discipline. There’s been real social shaming around it. And now we’re handing out a tool that quiets those cravings without ever asking: What’s behind them?

If food is being used to soothe stress, loneliness, boredom, or unprocessed emotions, the medication might silence the noise—but it won’t heal the wound. And once you stop taking it, you’re right back in the same pattern.

What My Most Successful Clients Do

They approach GLP-1s as part of a comprehensive system, not a replacement for one:

✓ Test and monitor. Gut microbiome testing, food sensitivity testing, metabolic baselines.

✓ Protect muscle relentlessly. Enough protein. Strength training 2-3x per week minimum. Non-negotiable.

✓ Support their gut. Fiber focused meals to support microbiome diversity. Adjusting based on follow-up testing.

✓ Work on what’s underneath the cravings. Address the physiological drivers (blood sugar, nutrients, gut health) AND the psychological patterns. Both matter.

My Bottom Line

GLP-1s don’t replace the work. They don’t fix root causes. But they do something powerful: They create space.

What you do with that space matters.

Where there’s a clear why, surrounded by a clear system, with clear goals and clear duration—GLP-1s can be phenomenal.

Without those pieces? It’s shaky.

This is the beginning of a much longer conversation about metabolic medicine, longevity, and what it actually means to be healthy.

I’m glad we’re finally having it.

Pooja